Thiopurine methyltransferase phenotypes and genotypes in Brazilians

被引:32
|
作者
Reis, M [1 ]
Santoro, A [1 ]
Suarez-Kurtz, G [1 ]
机构
[1] Inst Nacl Canc, Coordenacao Pesquisa, Div Farmacol, BR-20231050 Rio De Janeiro, RJ, Brazil
来源
PHARMACOGENETICS | 2003年 / 13卷 / 06期
关键词
TPMT; genetic polymorphism; Brazilians; thiopurines;
D O I
10.1097/00008571-200306000-00009
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The polymorphism of thiopurine methyltransferase (TPMT) was studied in 306 healthy Brazilians who were classed, on the basis of self-declared colour and ancestry, as Euro-derived (n = 81), Afro-derived (n = 18) or having interethnic admixture (n = 204). TPMT activity (range 0.17-25.93 U) displayed a trimodal distribution of high (> 11.3 U; 9% of individuals), intermediate (5-11.3 U; 9.8%) and low (0.17 U; 0.3%) phenotypes. The occurrence of the TPMT mutations 238G>C, 460G>A and 719A>G was investigated in all individuals with low or intermediate phenotype, and in 43 with high-activity phenotype. None and two mutant alleles were associated with high- or low-activity phenotypes, respectively, whereas one mutant allele was detected in 26 of the 30 intermediate phenotype individuals. The allele frequencies of TPMT*2, TPMT*3A and TPMT*3C did not differ between individuals classed as Euro-derived (0.76%, 2.03% and 2.54%, respectively) or having interethnic admixture (0.60%, 1.81% and 1.81%, respectively). Furthermore, within each of these groups, the frequencies of TPMT*3A and TPMT*3C were not significantly different. (C) 2003 Lippincott Williams Wilkins.
引用
收藏
页码:371 / 373
页数:3
相关论文
共 50 条
  • [1] Should Thiopurine Methyltransferase Genotypes and Phenotypes be Measured Before Thiopurine Therapy in Patients With Inflammatory Bowel Disease?
    Zhang Fangbin
    Gao Xiang
    Chen Minhu
    Ding Liang
    Xu Feng
    Huang Min
    Hu Pinjin
    THERAPEUTIC DRUG MONITORING, 2012, 34 (06) : 695 - 701
  • [2] Thiopurine S-methyltransferase activity in Nigerians: Phenotypes and activity reference values
    Adehin A.
    Bolaji O.O.
    BMC Research Notes, 11 (1)
  • [3] Analysis of thiopurine S-methyltransferase genotypes in children with acute lymphoblastic leukemia
    Elkaffash, D. M. N. E.
    Hassab, H. A. E.
    Abou Zeid, A. A.
    Elnily, D. A. E. M.
    Shaaban, I. O. A.
    FEBS JOURNAL, 2014, 281 : 546 - 546
  • [4] Analysis of Thiopurine S-Methyltransferase Genotypes in Japanese Patients with Inflammatory Bowel Disease
    Ban, Hiromitsu
    Andoh, Akira
    Tanaka, Aiko
    Tsujikawa, Tomoyuki
    Sasaki, Masaya
    Saito, Yasuharu
    Fujiyama, Yoshihide
    INTERNAL MEDICINE, 2008, 47 (19) : 1645 - 1648
  • [5] Pharmacogenetics of thiopurine S-Methyltransferase and thiopurine therapy
    Evans, WE
    THERAPEUTIC DRUG MONITORING, 2004, 26 (02) : 186 - 191
  • [6] Thiopurine pharmacogenetics: Clinical and molecular studies of thiopurine methyltransferase
    Weinshilboum, R
    DRUG METABOLISM AND DISPOSITION, 2001, 29 (04) : 601 - 605
  • [7] The clinical impact of thiopurine methyltransferase polymorphisms on thiopurine treatment
    Coulthard, SA
    Matheson, EC
    Hall, AG
    Hogarth, LA
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2004, 23 (8-9): : 1385 - 1391
  • [8] The effect of thiopurine methyltransferase on the cytotoxic action of thiopurine drugs
    Hogarth, LA
    Coulthard, SA
    Hall, AG
    Skitt, L
    LEUKEMIA, 2003, 17 (03) : 665 - 665
  • [9] The effect of thiopurine methyltransferase expression on sensitivity to thiopurine drugs
    Coulthard, SA
    Hogarth, LA
    Little, M
    Matheson, EC
    Redfern, CPF
    Minto, L
    Hall, AG
    MOLECULAR PHARMACOLOGY, 2002, 62 (01) : 102 - 109
  • [10] Thiopurine methyltransferase activity and azathioprine
    Walmsley, TA
    Florkowski, CM
    George, PM
    Pike, LS
    NEW ZEALAND MEDICAL JOURNAL, 2002, 115 (1156) : 302 - 302